Trials in Dallas, Texas
Here are the top 10 medical studies for lung cancer in Dallas, Texas
Popular Filters
Phase 3 Trials
Immunotherapy for Small Cell Lung Cancer
Recruiting1 awardPhase 3
Dallas, Texas
This trial is testing whether Durvalumab alone or with Tremelimumab can help patients with a specific type of lung cancer who have already had initial treatment. The drugs aim to boost the immune system to fight off any remaining cancer cells. Durvalumab and Tremelimumab are being studied together for their potential to improve cancer treatment outcomes.
Checkpoint Inhibitor
Immunotherapy + Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Fort Worth, Texas
This trial is testing two different ways to treat lung cancer that has spread, one with two immunotherapy drugs and one with just one immunotherapy drug, compared to just using chemotherapy drugs.
Tyrosine Kinase Inhibitor
Sitravatinib + Nivolumab for Advanced Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Dallas, Texas
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Anti-metabolites
Pembrolizumab + Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Fort Smith, Arkansas
This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.
Trials With No Placebo
Checkpoint Inhibitor
Pembrolizumab Combo for Lung Cancer
Recruiting1 awardPhase 2
Tyler, Texas
This trial is testing different combinations of cancer drugs to find the best treatment for patients with advanced lung cancer who haven't been treated before. The drugs help the immune system fight cancer or stop the cancer cells from growing.
BCL-2 Inhibitor
PF-06821497 for Small Cell Lung Cancer
Recruiting1 awardPhase 1
Dallas, Texas
This trial is testing a new drug called PF-06821497 to see if it can help adults with certain hard-to-treat cancers. The drug is taken by mouth and is being studied alone or with other treatments to check its safety and effectiveness in stopping cancer growth.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.